Effect of an inducible nitric oxide synthase inhibitor on differential flow-exhaled nitric oxide in asthmatic patients and healthy volunteers

Chest

Volumn 132, Issue 2, 2007, Pages 581-588

  Brindicci, Caterina ^a   Ito, Kazuhiro ^a   Barnes, Peter J ^a   Kharitonov, Sergei A ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Different flow rates; Nitric oxide; Nitric oxide inhibitor; Small airways

Indexed keywords

AMINOGUANIDINE; INDUCIBLE NITRIC OXIDE SYNTHASE; METHACHOLINE; NITRIC OXIDE SYNTHASE INHIBITOR; SALBUTAMOL; SODIUM CHLORIDE;

ADULT; ARTICLE; ASTHMA; BLOOD PRESSURE MEASUREMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; GENE OVEREXPRESSION; HUMAN; INFLAMMATION; LUNG ALVEOLUS EPITHELIUM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYSTEM; SKIN TEST;

EID: 34548012407     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-3046     Document Type: Article

References (26)

1. Yates DH, Kharitonov SA, Robbins RA, et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995; 152:892-896
2. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357:593-615
3. Gomez FP, Barbera JA, Roca J, et al. Effect of nitric oxide synthesis inhibition with nebulized L-NAME on ventilation-perfusion distributions in bronchial asthma. Eur Respir J 1998; 12:865-871
4. Taylor DA, McGrath JL, O'Connor BJ, et al. Allergen-induced early and late asthmatic responses are not affected by inhibition of endogenous nitric oxide. Am J Respir Crit Care Med 1998; 158:99-106
5. Hansel TT, Kharitonov SA, Donnelly LE, et al. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB J 2003; 17:1298-1300
6. Yates DH, Kharitonov SA, Thomas PS, et al. Endogenous nitric oxide is decreased in asthmatic patients by an inhibitor of inducible nitric oxide synthase. Am J Respir Crit Care Med 1996; 154:247-250
7. Brindicci C, Ito K, Resta O, et al. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005; 26:52-59
8. Lehtimaki L, Kankaanranta H, Saarelainen S, et al. Extended exhaled NO measurement differentiates between alveolar and bronchial inflammation. Am J Respir Crit Care Med 2001; 163:1557-1561
9. Hogman M, Holmkvist T, Wegener T, et al. Extended NO analysis applied to patients with COPD, allergic asthma and allergic rhinitis. Respir Med 2002; 96:24-30
10. Silkoff PE, Sylvester JT, Zamel N, et al. Airway nitric oxide diffusion in asthma: role in pulmonary function and bronchial responsiveness. Am J Respir Crit Care Med 2000; 161:1218-1228
11. van Veen IH, Sterk PJ, Schot R, et al. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006; 27:951-956
12. George SC, Hogman M, Permutt S, et al. Modeling pulmonary nitric oxide exchange. J Appl Physiol 2004; 96:831-839
13. Global Initiative for Asthma. Global strategy for asthma management and prevention: NHLBI/WHO workshop report. Bethesda, MD: National Institutes of Health, National Heart, Lung and Blood Institute, 2005; NIH Publication No. 02-3659
14. American Thoracic Society, European Respiratory Society. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005; 171:912-930
15. Kobzik L, Bredt DS, Lowenstein CJ, et al. Nitric oxide synthase in human and rat lung: immunocytochemical and histochemical localization. Am J Respir Cell Mol Biol 1993; 9:371-377
16. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993; 342:1510-1513
17. Robbins RA, Barnes PJ, Springall DR, et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem Biophys Res Commun 1994; 203:209-218
18. Singh S, Evans TW. Nitric oxide, the biological mediator of the decade: fact or fiction? Eur Respir J 1997; 10:699-707
19. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001; 163:1693-1722
20. Hart CM. Nitric oxide in adult lung disease. Chest 1999; 115:1407-1417
21. Koarai A, Ichinose M, Sugiura H, et al. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther 2000; 13:267-275
22. Tulic MK, Wale JL, Holt PG, et al. Differential effects of nitric oxide synthase inhibitors in an in vivo allergic rat model. Eur Respir J 2000; 15:870-877
23. Trifilieff A, Fujitani Y, Mentz F, et al. Inducible nitric oxide synthase inhibitors suppress airway inflammation in mice through down-regulation of chemokine expression. J Immunol 2000; 165:1526-1533
24. Xiong Y, Karupiah G, Hogan SP, et al. Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 1999; 162:445-452
25. Stirling RG, Kharitonov SA, Campbell D, et al. Increase in exhaled nitric oxide levels in patients with difficult asthma and correlation with symptoms and disease severity despite treatment with oral and inhaled corticosteroids: Asthma and Allergy Group. Thorax 1998; 53:1030-1034
26. Taylor DA, McGrath JL, Orr LM, et al. Effect of endogenous nitric oxide inhibition on airway responsiveness to histamine and adenosine-5′- monophosphate in asthma. Thorax 1998; 53:483-489